{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:40:06Z","timestamp":1745577606106,"version":"3.40.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00277-025-06282-5","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T14:01:06Z","timestamp":1740751266000},"page":"2005-2011","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["t(14;22)(q32;q11) translocation involving IGH and IGL acquired at progression of splenic marginal zone lymphoma treated with rituximab, ibrutinib, and obinutuzumab"],"prefix":"10.1007","volume":"104","author":[{"given":"Julia T.","family":"Geyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Kluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"issue":"7","key":"6282_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave SS, de Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint A Jr., Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"issue":"4","key":"6282_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","volume":"5","author":"R Kuppers","year":"2005","unstructured":"Kuppers R (2005) Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 5(4):251\u2013262. https:\/\/doi.org\/10.1038\/nrc1589","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"6282_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMra2102568","volume":"386","author":"D Rossi","year":"2022","unstructured":"Rossi D, Bertoni F, Zucca E (2022) Marginal-Zone lymphomas. N Engl J Med 386(6):568\u2013581. https:\/\/doi.org\/10.1056\/NEJMra2102568","journal-title":"N Engl J Med"},{"issue":"9","key":"6282_CR4","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","volume":"116","author":"M Salido","year":"2010","unstructured":"Salido M, Baro C, Oscier D, Stamatopoulos K, Dierlamm J, Matutes E, Traverse-Glehen A, Berger F, Felman P, Thieblemont C, Gesk S, Athanasiadou A, Davis Z, Gardiner A, Milla F, Ferrer A, Mollejo M, Calasanz MJ, Florensa L, Espinet B, Luno E, Wlodarska I, Verhoef G, Garcia-Granero M, Salar A, Papadaki T, Serrano S, Piris MA, Sole F (2010) Cytogenetic aberrations and their prognostic value in a series of 330 Splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell lymphoma group. Blood 116(9):1479\u20131488. https:\/\/doi.org\/10.1182\/blood-2010-02-267476","journal-title":"Blood"},{"issue":"1","key":"6282_CR5","first-page":"71","volume":"86","author":"F Sole","year":"2001","unstructured":"Sole F, Salido M, Espinet B, Garcia JL, Martinez Climent JA, Granada I, Hernandez JM, Benet I, Piris MA, Mollejo M, Martinez P, Vallespi T, Domingo A, Serrano S, Woessner S, Florensa L (2001) Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Haematologica 86(1):71\u201377","journal-title":"Haematologica"},{"issue":"5","key":"6282_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","volume":"117","author":"A Rinaldi","year":"2011","unstructured":"Rinaldi A, Mian M, Chigrinova E, Arcaini L, Bhagat G, Novak U, Rancoita PM, De Campos CP, Forconi F, Gascoyne RD, Facchetti F, Ponzoni M, Govi S, Ferreri AJ, Mollejo M, Piris MA, Baldini L, Soulier J, Thieblemont C, Canzonieri V, Gattei V, Marasca R, Franceschetti S, Gaidano G, Tucci A, Uccella S, Tibiletti MG, Dirnhofer S, Tripodo C, Doglioni C, Dalla Favera R, Cavalli F, Zucca E, Kwee I, Bertoni F (2011) Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood 117(5):1595\u20131604. https:\/\/doi.org\/10.1182\/blood-2010-01-264275","journal-title":"Blood"},{"issue":"1","key":"6282_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/bjh.17141","volume":"193","author":"B Gailllard","year":"2021","unstructured":"Gailllard B, Cornillet-Lefebvre P, Le QH, Maloum K, Pannetier M, Lecoq-Lafon C, Grange B, Jondreville L, Michaux L, Nadal N, Ittel A, Luquet I, Struski S, Lefebvre C, Gaillard JB, Lafage-Pochitaloff M, Balducci E, Penther D, Barin C, Collonge-Rame MA, Jimenez-Poquet M, Richebourg S, Lemaire P, Defasque S, Radford-Weiss I, Bidet A, Susin SA, Nguyen-Khac F, Chapiro E, Groupe Francophone de Cytogenetique H (2021) Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of Splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities. Br J Haematol 193(1):72\u201382. https:\/\/doi.org\/10.1111\/bjh.17141","journal-title":"Br J Haematol"},{"issue":"6","key":"6282_CR8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/sj.leu.2405027","volume":"22","author":"ED Remstein","year":"2008","unstructured":"Remstein ED, Law M, Mollejo M, Piris MA, Kurtin PJ, Dogan A (2008) The prevalence of IG translocations and 7q32 deletions in Splenic marginal zone lymphoma. Leukemia 22(6):1268\u20131272. https:\/\/doi.org\/10.1038\/sj.leu.2405027","journal-title":"Leukemia"},{"issue":"7","key":"6282_CR9","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/sj.leu.2404695","volume":"21","author":"JI Martin-Subero","year":"2007","unstructured":"Martin-Subero JI, Ibbotson R, Klapper W, Michaux L, Callet-Bauchu E, Berger F, Calasanz MJ, De Wolf-Peeters C, Dyer MJ, Felman P, Gardiner A, Gascoyne RD, Gesk S, Harder L, Horsman DE, Kneba M, Kuppers R, Majid A, Parry-Jones N, Ritgen M, Salido M, Sole F, Thiel G, Wacker HH, Oscier D, Wlodarska I, Siebert R (2007) A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation. Leukemia 21(7):1532\u20131544. https:\/\/doi.org\/10.1038\/sj.leu.2404695","journal-title":"Leukemia"},{"issue":"1","key":"6282_CR10","first-page":"448","volume":"11","author":"S Abe","year":"2018","unstructured":"Abe S, Katsushima H, Fujishima F, Nomura J, Kameoka J, Ichinohasama R (2018) A case study of t(14;22)(q32;q11) involving Immunoglobulin heavy and light chain in follicular lymphoma. Int J Clin Exp Pathol 11(1):448\u2013454","journal-title":"Int J Clin Exp Pathol"},{"issue":"8","key":"6282_CR11","first-page":"5221","volume":"7","author":"K Li","year":"2014","unstructured":"Li K, Johnson RL, Li S, Thorson JA, Mulroney CM, Dell\u2019Aquila ML, Wang HY (2014) Nodal involvement by marginal zone B-cell lymphoma harboring t(14;22)(q32;q11) involving Immunoglobulin heavy chain and light chain lambda as the sole karyotypically recognizable abnormality in a patient with systemic lupus erythematosus. Int J Clin Exp Pathol 7(8):5221\u20135231","journal-title":"Int J Clin Exp Pathol"},{"key":"6282_CR12","doi-asserted-by":"publisher","unstructured":"Moore JM-JRJHS (2020) An International System for Human Cytogenomic Nomenclature 2020. S.Karger AG. https:\/\/doi.org\/10.1159\/isbn.978-3-318-06867-2","DOI":"10.1159\/isbn.978-3-318-06867-2"},{"issue":"4","key":"6282_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/path.5209","volume":"247","author":"A Xochelli","year":"2019","unstructured":"Xochelli A, Bikos V, Polychronidou E, Galigalidou C, Agathangelidis A, Charlotte F, Moschonas P, Davis Z, Colombo M, Roumelioti M, Sutton LA, Groenen P, van den Brand M, Boudjoghra M, Algara P, Traverse-Glehen A, Ferrer A, Stalika E, Karypidou M, Kanellis G, Kalpadakis C, Mollejo M, Pangalis G, Vlamos P, Amini RM, Pospisilova S, Gonzalez D, Ponzoni M, Anagnostopoulos A, Giudicelli V, Lefranc MP, Espinet B, Panagiotidis P, Piris MA, Du MQ, Rosenquist R, Papadaki T, Belessi C, Ferrarini M, Oscier D, Tzovaras D, Ghia P, Davi F, Hadzidimitriou A, Stamatopoulos K (2019) Disease-biased and shared characteristics of the Immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations. J Pathol 247(4):416\u2013421. https:\/\/doi.org\/10.1002\/path.5209","journal-title":"J Pathol"},{"issue":"1","key":"6282_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","volume":"31","author":"E Zucca","year":"2020","unstructured":"Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, Ricardi U, Salar A, Stamatopoulos K, Thieblemont C, Wotherspoon A, Ladetto M, clinicalguidelines@esmo.org EGCEa (2020) Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(1):17\u201329. https:\/\/doi.org\/10.1016\/j.annonc.2019.10.010","journal-title":"Ann Oncol"},{"issue":"4","key":"6282_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/PPO.0000000000000463","volume":"26","author":"F Bertoni","year":"2020","unstructured":"Bertoni F, Rossi D, Raderer M, Zucca E (2020) Marginal zone lymphomas. Cancer J 26(4):336\u2013347. https:\/\/doi.org\/10.1097\/PPO.0000000000000463","journal-title":"Cancer J"},{"issue":"6","key":"6282_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/j.1365-2141.2005.05688.x","volume":"130","author":"HV Aamot","year":"2005","unstructured":"Aamot HV, Bjornslett M, Delabie J, Heim S (2005) t(14;22)(q32;q11) in non-Hodgkin lymphoma and myeloid leukaemia: molecular cytogenetic investigations. Br J Haematol 130(6):845\u2013851. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05688.x","journal-title":"Br J Haematol"},{"key":"6282_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.leukres.2016.11.005","volume":"52","author":"YH Zhang","year":"2017","unstructured":"Zhang YH, Lu AD, Yang L, Li LD, Chen WM, Long LY, Zhang LP, Qin YZ (2017) PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy. Leuk Res 52:43\u201349. https:\/\/doi.org\/10.1016\/j.leukres.2016.11.005","journal-title":"Leuk Res"},{"issue":"5","key":"6282_CR18","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1111\/ajco.12586","volume":"13","author":"SH Pan","year":"2017","unstructured":"Pan SH, Su KY, Spiessens B, Kusuma N, Delahaye NF, Gruselle O, Myo A, de Creus A, Louahed J, Chang GC, Yu SL, Yang PC (2017) Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patients. Asia Pac J Clin Oncol 13(5):e212\u2013e223. https:\/\/doi.org\/10.1111\/ajco.12586","journal-title":"Asia Pac J Clin Oncol"},{"issue":"2","key":"6282_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/cre2.267","volume":"6","author":"K Hatano","year":"2020","unstructured":"Hatano K, Saigo C, Kito Y, Shibata T, Takeuchi T (2020) Overexpression of JAG2 is related to poor outcomes in oral squamous cell carcinoma. Clin Exp Dent Res 6(2):174\u2013180. https:\/\/doi.org\/10.1002\/cre2.267","journal-title":"Clin Exp Dent Res"},{"issue":"12","key":"6282_CR20","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1182\/blood-2003-12-4114","volume":"104","author":"C Houde","year":"2004","unstructured":"Houde C, Li Y, Song L, Barton K, Zhang Q, Godwin J, Nand S, Toor A, Alkan S, Smadja NV, Avet-Loiseau H, Lima CS, Miele L, Coignet LJ (2004) Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood 104(12):3697\u20133704. https:\/\/doi.org\/10.1182\/blood-2003-12-4114","journal-title":"Blood"},{"issue":"12","key":"6282_CR21","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","volume":"107","author":"L Arcaini","year":"2006","unstructured":"Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M, Morra E, Gambacorta M, Cortelazzo S, Tucci A, Ungari M, Ambrosetti A, Menestrina F, Orsucci L, Novero D, Pulsoni A, Frezzato M, Gaidano G, Vallisa D, Minardi V, Tripodo C, Callea V, Baldini L, Merli F, Federico M, Franco V, Iannitto E, Integruppo Italiano L (2006) Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 107(12):4643\u20134649. https:\/\/doi.org\/10.1182\/blood-2005-11-4659","journal-title":"Blood"},{"issue":"5","key":"6282_CR22","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","volume":"100","author":"JI Chacon","year":"2002","unstructured":"Chacon JI, Mollejo M, Munoz E, Algara P, Mateo M, Lopez L, Andrade J, Carbonero IG, Martinez B, Piris MA, Cruz MA (2002) Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood 100(5):1648\u20131654","journal-title":"Blood"},{"issue":"2","key":"6282_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0002-9440(10)63862-X","volume":"162","author":"A Tierens","year":"2003","unstructured":"Tierens A, Delabie J, Malecka A, Wang J, Gruszka-Westwood A, Catovsky D, Matutes E (2003) Splenic marginal zone lymphoma with villous lymphocytes shows on-going Immunoglobulin gene mutations. Am J Pathol 162(2):681\u2013689. https:\/\/doi.org\/10.1016\/S0002-9440(10)63862-X","journal-title":"Am J Pathol"},{"issue":"1","key":"6282_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/bjh.17815","volume":"196","author":"G Bastidas-Mora","year":"2022","unstructured":"Bastidas-Mora G, Bea S, Navarro A, Gine E, Costa D, Delgado J, Baumann T, Magnano L, Rivas-Delgado A, Villamor N, Colomer D, Lopez-Guerra M, Rozman M, Balague O, Martinez D, Baptista MJ, Escoda L, Alcoceba M, Blanes M, Climent F, Campo E, Wotherspoon A, Lopez-Guillermo A, Matutes E (2022) Clinico-biological features and outcome of patients with Splenic marginal zone lymphoma with histological transformation. Br J Haematol 196(1):146\u2013155. https:\/\/doi.org\/10.1111\/bjh.17815","journal-title":"Br J Haematol"},{"issue":"4","key":"6282_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/path.2665","volume":"220","author":"AJ Watkins","year":"2010","unstructured":"Watkins AJ, Huang Y, Ye H, Chanudet E, Johnson N, Hamoudi R, Liu H, Dong G, Attygalle A, McPhail ED, Law ME, Isaacson PG, de Leval L, Wotherspoon A, Du MQ (2010) Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis. J Pathol 220(4):461\u2013474. https:\/\/doi.org\/10.1002\/path.2665","journal-title":"J Pathol"},{"issue":"5","key":"6282_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1182\/blood.2021012386","volume":"139","author":"F Bonfiglio","year":"2022","unstructured":"Bonfiglio F, Bruscaggin A, Guidetti F, Terzi di Bergamo L, Faderl M, Spina V, Condoluci A, Bonomini L, Forestieri G, Koch R, Piffaretti D, Pini K, Pirosa MC, Cittone MG, Arribas A, Lucioni M, Ghilardi G, Wu W, Arcaini L, Baptista MJ, Bastidas G, Bea S, Boldorini R, Broccoli A, Buehler MM, Canzonieri V, Cascione L, Ceriani L, Cogliatti S, Corradini P, Derenzini E, Devizzi L, Dietrich S, Elia AR, Facchetti F, Gaidano G, Garcia JF, Gerber B, Ghia P, Gomes da Silva M, Gritti G, Guidetti A, Hitz F, Inghirami G, Ladetto M, Lopez-Guillermo A, Lucchini E, Maiorana A, Marasca R, Matutes E, Meignin V, Merli M, Moccia A, Mollejo M, Montalban C, Novak U, Oscier DG, Passamonti F, Piazza F, Pizzolitto S, Rambaldi A, Sabattini E, Salles G, Santambrogio E, Scarfo L, Stathis A, Stussi G, Geyer JT, Tapia G, Tarella C, Thieblemont C, Tousseyn T, Tucci A, Vanini G, Visco C, Vitolo U, Walewska R, Zaja F, Zenz T, Zinzani PL, Khiabanian H, Calcinotto A, Bertoni F, Bhagat G, Campo E, De Leval L, Dirnhofer S, Pileri SA, Piris MA, Traverse-Glehen A, Tzankov A, Paulli M, Ponzoni M, Mazzucchelli L, Cavalli F, Zucca E, Rossi D (2022) Genetic and phenotypic attributes of Splenic marginal zone lymphoma. Blood 139(5):732\u2013747. https:\/\/doi.org\/10.1182\/blood.2021012386","journal-title":"Blood"},{"issue":"18","key":"6282_CR27","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","volume":"21","author":"M Parry","year":"2015","unstructured":"Parry M, Rose-Zerilli MJ, Ljungstrom V, Gibson J, Wang J, Walewska R, Parker H, Parker A, Davis Z, Gardiner A, McIver-Brown N, Kalpadakis C, Xochelli A, Anagnostopoulos A, Fazi C, de Castro DG, Dearden C, Pratt G, Rosenquist R, Ashton-Key M, Forconi F, Collins A, Ghia P, Matutes E, Pangalis G, Stamatopoulos K, Oscier D, Strefford JC (2015) Genetics and prognostication in Splenic marginal zone lymphoma: revelations from deep sequencing. Clin Cancer Res 21(18):4174\u20134183. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2759","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06282-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06282-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06282-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:10:59Z","timestamp":1745575859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06282-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6282"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06282-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted following the Declaration of Helsinki and approved by Institutional Review Boards. Written consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}